Sulfur hexafluoride lipid microsphere
Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| lumason | New Drug Application | 2025-07-22 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml |
Clinical
Clinical Trials
202 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 1 | 4 | 1 | 13 | 20 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | 1 | 1 | 10 | 13 |
| Retinal perforations | D012167 | EFO_1001028 | — | 1 | — | — | 1 | 9 | 11 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | 1 | 8 | 10 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | 3 | 2 | 6 |
| Abdominal injuries | D000007 | — | — | 2 | 2 | — | 3 | 1 | 6 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 1 | 1 | 3 | 5 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 2 | — | 1 | 1 | 4 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | — | 1 | 2 | 4 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | — | 1 | 3 | 4 |
Show 8 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | 1 | 1 | — | 12 | 14 |
| Neoplasms | D009369 | — | C80 | 3 | 3 | 1 | — | 5 | 9 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 1 | 1 | 2 | — | 3 | 7 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | 6 | 7 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | — | 1 | — | 4 | 6 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 1 | 1 | — | 2 | 6 |
| Ischemic stroke | D000083242 | — | — | — | 1 | 2 | — | 2 | 5 |
| Carotid stenosis | D016893 | — | — | — | 1 | 1 | — | 3 | 5 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | 1 | — | 1 | — | 2 | 4 |
| Coronary disease | D003327 | — | — | 1 | 1 | 2 | — | 1 | 4 |
Show 24 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dissociative disorders | D004213 | — | F44.1 | — | 1 | — | — | 9 | 10 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 2 | — | — | 5 | 7 |
| Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | 2 | 4 |
| Adenocarcinoma | D000230 | — | — | — | 1 | — | — | 3 | 4 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 2 | — | — | 1 | 3 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | — | — | 2 | 3 |
| Kidney transplantation | D016030 | — | — | 1 | 1 | — | — | 1 | 3 |
| Anterior wall myocardial infarction | D056988 | EFO_1000812 | — | — | 1 | — | — | 1 | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | — | — | — | 2 |
| Pancreatic ductal carcinoma | D021441 | — | — | — | 1 | — | — | 1 | 2 |
Show 18 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibrosis | D005355 | — | — | 2 | — | — | — | 2 | 4 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | — | — | — | 2 | 3 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | 1 | 2 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | — | — | — | 1 | 2 |
| Obstructive lung diseases | D008173 | — | — | 1 | — | — | — | 1 | 2 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | 1 | — | — | — | — | 1 |
| Embolism | D004617 | — | — | 1 | — | — | — | — | 1 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
| Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | 1 | — | — | — | — | 1 |
| Lung transplantation | D016040 | — | — | 1 | — | — | — | — | 1 |
Show 18 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fuchs' endothelial dystrophy | D005642 | EFO_0003946 | H18.51 | — | — | — | — | 4 | 4 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 3 | 3 |
| Microcirculation | D008833 | — | — | — | — | — | — | 3 | 3 |
| Edema | D004487 | — | R60.9 | — | — | — | — | 2 | 2 |
| Vision disorders | D014786 | — | H53.11 | — | — | — | — | 2 | 2 |
| Hereditary corneal dystrophies | D003317 | — | H18.5 | — | — | — | — | 2 | 2 |
| Cataract | D002386 | EFO_0001059 | H26.9 | — | — | — | — | 2 | 2 |
| Colonic neoplasms | D003110 | — | C18 | — | — | — | — | 2 | 2 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | — | — | 2 | 2 |
| Healthy volunteers/patients | — | — | — | — | — | — | — | 2 | 2 |
Show 89 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Sulfur hexafluoride lipid microsphere |
| INN | — |
| Description | Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL3545306 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Lumason
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,122 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use